Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin in Early Alzheimer's Disease
NCT00581867Phase 2Completed
- Start
- Oct 2007
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Intranasal Insulin Aspart with Intranasal Saline (placebo) (2 arms). Primary endpoint: fMRI Measure of Hippocampal Activation at 30 minutes. Started Oct 2007; status: completed.
02
Drugs
insulin aspart
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00581867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581867.